BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

526301

MEDINOV

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MEDINOVA DIAGNOSTIC SERVICES L Share Price Update

As of the latest trading session, MEDINOVA DIAGNOSTIC SERVICES L share price is currently at ₹ 42.43, which is up by ₹ 0.97 from its previous closing. Today, the stock has fluctuated between ₹ 41.40 and ₹ 43.90. Over the past year, MEDINOVA DIAGNOSTIC SERVICES L has achieved a return of -0.19 %. In the last month alone, the return has been 9.19 %. Read More...

MEDINOVA DIAGNOSTIC SERVICES L fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    42.35

  • P/E Ratio (TTM)

    45.55

  • Beta

    0.64

  • Book Value / share

    -1.63

  • Return on equity

    6.76%

  • EPS (TTM)

    0.91

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.20

info icon alternate text

MEDINOVA DIAGNOSTIC SERVICES L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 1.75
Operating Expense 1.56
Net Profit 0.20
Net Profit Margin (%) 11.42
Earnings Per Share (EPS) 0.20
EBITDA 0.41
Effective Tax Rate (%) 16.66
Particulars SEP 2024 (Values in Cr)
Revenue 1.98
Operating Expense 1.66
Net Profit 0.25
Net Profit Margin (%) 12.62
Earnings Per Share (EPS) 0.25
EBITDA 0.51
Effective Tax Rate (%) 29.41
Particulars JUN 2024 (Values in Cr)
Revenue 1.86
Operating Expense 1.65
Net Profit 0.17
Net Profit Margin (%) 9.13
Earnings Per Share (EPS) 0.17
EBITDA 0.37
Effective Tax Rate (%) 22.72
Particulars MAR 2024 (Values in Cr)
Revenue 1.92
Operating Expense 1.68
Net Profit 0.29
Net Profit Margin (%) 15.10
Earnings Per Share (EPS) 0.30
EBITDA 0.56
Effective Tax Rate (%) 25.64
Particulars DEC 2023 (Values in Cr)
Revenue 1.82
Operating Expense 1.70
Net Profit 0.12
Net Profit Margin (%) 6.59
Earnings Per Share (EPS) 0.12
EBITDA 0.33
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 7.78
Operating Expense 7.02
Net Profit 0.75
Net Profit Margin (%) 9.64
Earnings Per Share (EPS) 0.75
EBITDA 1.71
Effective Tax Rate (%) 25.49
Particulars MAR 2023 (Values in Cr)
Revenue 7.76
Operating Expense 7.13
Net Profit 0.63
Net Profit Margin (%) 8.11
Earnings Per Share (EPS) 0.63
EBITDA 1.69
Effective Tax Rate (%) 27.58
Particulars MAR 2022 (Values in Cr)
Revenue 11.51
Operating Expense 9.18
Net Profit 2.07
Net Profit Margin (%) 17.98
Earnings Per Share (EPS) 2.08
EBITDA 3.21
Effective Tax Rate (%) 18.82
Particulars MAR 2021 (Values in Cr)
Revenue 11.32
Operating Expense 9.32
Net Profit 2.17
Net Profit Margin (%) 19.16
Earnings Per Share (EPS) 2.17
EBITDA 2.92
Effective Tax Rate (%) 5.67
Particulars MAR 2020 (Values in Cr)
Revenue 5.49
Operating Expense 6.02
Net Profit -0.30
Net Profit Margin (%) -5.46
Earnings Per Share (EPS) -0.30
EBITDA 0.55
Effective Tax Rate (%) -11.11
Particulars MAR 2024 (Values in Cr)
Book Value / Share -3.14
ROE % 18.01
ROCE % 17.34
Total Debt to Total Equity 0.00
EBITDA Margin 29.79
Particulars MAR 2023 (Values in Cr)
Book Value / Share -5.16
ROE % 15.05
ROCE % 14.61
Total Debt to Total Equity 0.00
EBITDA Margin 28.83
Particulars MAR 2022 (Values in Cr)
Book Value / Share -6.84
ROE % 21.44
ROCE % 19.76
Total Debt to Total Equity 0.00
EBITDA Margin 29.55
Particulars MAR 2021 (Values in Cr)
Book Value / Share -7.23
ROE % 196.40
ROCE % 36.35
Total Debt to Total Equity 0.00
EBITDA Margin 24.65
Particulars MAR 2020 (Values in Cr)
Book Value / Share -9.21
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 17.05
Particulars MAR 2024 (Values in Cr)
Book Value / Share -2.07
ROE % 6.76
ROCE % 9.69
Total Debt to Total Equity 0.00
EBITDA Margin 22.49
Particulars MAR 2023 (Values in Cr)
Book Value / Share -2.84
ROE % 5.68
ROCE % 8.63
Total Debt to Total Equity 0.00
EBITDA Margin 22.16
Particulars MAR 2022 (Values in Cr)
Book Value / Share -3.48
ROE % 18.65
ROCE % 18.82
Total Debt to Total Equity 0.00
EBITDA Margin 28.32
Particulars MAR 2021 (Values in Cr)
Book Value / Share -5.58
ROE % 126.53
ROCE % 44.50
Total Debt to Total Equity 0.00
EBITDA Margin 25.80
Particulars MAR 2020 (Values in Cr)
Book Value / Share -7.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 10.20
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.91
Total Assets 5.38
Total Liabilities 5.38
Total Equity -3.12
Share Outstanding 9981640
Price to Book Ratio -14.82
Return on Assets (%) 37.15
Return on Capital (%) 106.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 4.47
Total Liabilities 4.47
Total Equity -5.13
Share Outstanding 9981640
Price to Book Ratio -6.18
Return on Assets (%) 37.17
Return on Capital (%) 271.07
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.31
Total Assets 4.44
Total Liabilities 4.44
Total Equity -6.80
Share Outstanding 9981640
Price to Book Ratio -9.08
Return on Assets (%) 51.08
Return on Capital (%) -534.7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 4.37
Total Liabilities 4.37
Total Equity -7.50
Share Outstanding 9981640
Price to Book Ratio -4.10
Return on Assets (%) 46.24
Return on Capital (%) -66.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 4.05
Total Liabilities 4.05
Total Equity -9.36
Share Outstanding 9981640
Price to Book Ratio -1.84
Return on Assets (%) -6.36
Return on Capital (%) 6.41
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 6.01
Total Liabilities 6.01
Total Equity -2.06
Share Outstanding 9981640
Price to Book Ratio -14.82
Return on Assets (%) 12.52
Return on Capital (%) 25.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 6.33
Total Liabilities 6.33
Total Equity -2.83
Share Outstanding 9981640
Price to Book Ratio -6.18
Return on Assets (%) 9.94
Return on Capital (%) 21.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.30
Total Assets 6.68
Total Liabilities 6.68
Total Equity -3.46
Share Outstanding 9981640
Price to Book Ratio -9.08
Return on Assets (%) 31.02
Return on Capital (%) 90.91
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 4.63
Total Liabilities 4.63
Total Equity -5.55
Share Outstanding 9981640
Price to Book Ratio -4.10
Return on Assets (%) 46.74
Return on Capital (%) -94.83
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 4.02
Total Liabilities 4.02
Total Equity -7.67
Share Outstanding 9981640
Price to Book Ratio -1.84
Return on Assets (%) -7.35
Return on Capital (%) 8.1
Particulars MAR 2024 (Values in Cr)
Net Income 2.27
Cash from Operations 2.76
Cash from Investing -0.20
Cash from Financing -1.32
Net change in Cash 1.13
Free Cash Flow 2.98
Particulars MAR 2023 (Values in Cr)
Net Income 1.90
Cash from Operations 1.49
Cash from Investing -0.33
Cash from Financing -0.85
Net change in Cash 0.22
Free Cash Flow 1.88
Particulars MAR 2022 (Values in Cr)
Net Income 2.79
Cash from Operations 1.85
Cash from Investing -1.83
Cash from Financing 0.31
Net change in Cash -0.17
Free Cash Flow 2.02
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 1.66
Cash from Investing -0.06
Cash from Financing -1.37
Net change in Cash 0.24
Free Cash Flow 1.84
Particulars MAR 2020 (Values in Cr)
Net Income -0.27
Cash from Operations 1.27
Cash from Investing -0.15
Cash from Financing -1.07
Net change in Cash 0.00
Free Cash Flow 1.29
Particulars MAR 2024 (Values in Cr)
Net Income 1.01
Cash from Operations 1.60
Cash from Investing -0.18
Cash from Financing -1.32
Net change in Cash 0.00
Free Cash Flow 1.79
Particulars MAR 2023 (Values in Cr)
Net Income 0.87
Cash from Operations 1.25
Cash from Investing -0.33
Cash from Financing -0.78
Net change in Cash 0.06
Free Cash Flow 1.64
Particulars MAR 2022 (Values in Cr)
Net Income 2.55
Cash from Operations 1.63
Cash from Investing -1.83
Cash from Financing 0.94
Net change in Cash 0.23
Free Cash Flow 1.80
Particulars MAR 2021 (Values in Cr)
Net Income 2.29
Cash from Operations 1.47
Cash from Investing -0.11
Cash from Financing -1.15
Net change in Cash 0.24
Free Cash Flow 1.66
Particulars MAR 2020 (Values in Cr)
Net Income -0.26
Cash from Operations 0.49
Cash from Investing -0.14
Cash from Financing -0.26
Net change in Cash 0.01
Free Cash Flow 0.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 76.74 13.41 100542.86 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.74 192.05 4.94 147.57 51.01 / 98.70
SHREE PACETRONIX LTD. 71.00 14.79 1.90 25.56 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.75 0.00 2.62 28.41 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 83.66 12.27 100542.86 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 31.25 0.00 -16.74 23.34 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5584.95 29.60 6.27 6109.94 3750.00 / 6400.00

MEDINOVA DIAGNOSTIC SERVICES L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
42.01 1.35 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 41.10
  • 26 Days 39.20
  • 10 Days 40.50
  • 50 Days 38.60
  • 12 Days 40.20
  • 100 Days 38.30
  • 20 Days 39.50
  • 200 Days 37.70
41.17 PIVOT

First Support

40.43

First Resistance

42.18

Second Support

39.42

Second Resistance

42.92

Third Support

38.68

Third Resistance

43.93

RSI

61.83

ADX

18.49

MACD

1.03

Williams % R

-13.43

Commodity Channel Index (CCI)

94.68

Date

2025-04-29

Week

4360.00

Same Day

2503.00

Month

5991.00

1 Year

0.65

3 Year

0.43

Over 1 Month

9.19%

down

Over 1 Year

-0.19%

down

Over 3 Months

15.94%

down

Over 3 Years

6.15%

down

Over 6 Months

9.16%

down

Over 5 Years

21.35%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

MEDINOVA DIAGNOSTIC SERVICES L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
37.86%
Promoter Holdings
62.13%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Vijaya Diagnostic Centre Limited 6202220.0 (62.14%) Shareholding of Promoter and Promoter Group
Shankar Lal Saraf 326500.0 (3.27%) Public Shareholding
Subba Lakshmi Champati 297824.0 (2.98%) Public Shareholding
Kattamreddy Lakshminarayana Reddy 125000.0 (1.25%) Public Shareholding
Padarthi Harinadha Reddy 125000.0 (1.25%) Public Shareholding
Rajani Vaddi 117599.0 (1.18%) Public Shareholding
Duvvuru Jalandhar Reddy 100000.0 (1.0%) Public Shareholding
Muddu Krishna Reddy Oduru 100000.0 (1.0%) Public Shareholding

News

Left Arrow
Right Arrow

MEDINOVA DIAGNOSTIC SERVICES L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

MEDINOVA DIAGNOSTIC SERVICES L Share Price

Medinova Diagnostic Services Ltd (MDSL), incorporated in Mar.'93, commenced business on 26 Mar.'93. It belongs to Standard Organics group. The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology.

MDSL has acquired the business and undertaking of the diagnostic services division of Standard Medical & Pharmaceuticals (SMPL) as a going concern together with assets and liabilities from 1 Apr.'93. It has four main diagnostic centres in Hyderabad, Bangalore, Pune, and Kolkata apart from mini/medium-sized franchise centres at Karimnagar, Mancherial, Vizag, Nellore.

MDSL came out with a public issue of 67.50 lac equity shares at par, aggregating Rs 6.75 cr, in Nov.'93. The company has installed three magnetic resonance imaging units and other equipment with the latest technology in diagnostic centres in Hyderabad and Bangalore, at a capital outlay of Rs 10 cr.

MDSL has completed a consultancy assignment for an overseas project in Abuja, Nigeria, earning valuable foreign exchange. A new CT machine was installed in Hyderabad in Feb.'95.

In the year 1996-97 the company Medinova- Hyderabad has achieved the ISO 9002 Certification. With this the Company was the first to obtain ISO 9002 certification in the field of medical diagnostics. The company has opened a medium sized Centre at Pimpri (Pune) as a part of its expansion plan.

During 1998-99, The Company installed a Magnetic Resonance Imaging Unit (MRI) and the latest model of Auto Analyser Hitachi 902 at the Hyderabad Unit and a Color Doppler SONOS 2500 supplied by M/s Hewlett Packard has been installed at Kolkata Centre.

A new CT scan machines was installed at Pune and Kolkata and a Cardiac equipment at Bangalore was also installed. A new and innonvative health schemes has to be flagged off to increase the revenues for the company.

A new Cell Counter Machine for Haematology Department was installed in 2005; new Auto Analyser for Biochemistry Department was installed during 2006 at Kolkata centre; new Ultrasound Machine got installed in 2007 at Kolkata centre. In 2008, it installed new Auto Analyzer, Cell Counter and Semi Auto Analyzer machines at Pune and Hyderabad Centres. Equipments like Ultrasound, System, Digital Color Doppler and X Ray were acquired in 2009. Further, equipments such as Computed Radiography System and Semi Auto Analyzers got launched to upgrade the centres in 2010. Colour Droppler, Ultra Sound and Stress Test Machines were acquired in 2011. The Centres got upgraded by acquiring new CT Machine, Digital X-ray & Ultrasound Scanners in 2012.

During the year 2014, Bangalore Unit of the Company was sold/transferred as-a-going-concern, on slump sale basis together with all its assets and liabilities, to M/s. Mallya Hospital (Purchaser) for a total consideration of Rs.715 lakhs, through which the transaction got completed and the sale became effective from January 31, 2014. Post sale of the Bangalore unit, the Company's retained business include the diagnostic service centres at Hyderabad, Pune, Kolkata and a mini centre at Bansdroni (Kolkata). Similarly, in 2014, M/s. Vijaya Diagnostic Centre Private Limited acquired 24.54% shares of the Company equivalent to 29.01% (29.16% of Voting Capital of MDSL) shareholding from the erstwhile Promoter M/s. Standard Medical & Pharmaceuticals Limited and made open offer for additional 26% of the Equity Shares. Consequently, M/s. Vijaya Diagnostic Centre Private Limited after completion of the open offer and acquisition of shares acquired the Management Control and became the Promoter of the Company.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Medinova Diagnostic Services Ltd?

Answer Field

The share price of Medinova Diagnostic Services Ltd for NSE is ₹ 0.00 and for BSE is ₹ 42.01.

What is the Market Cap of Medinova Diagnostic Services Ltd?

Answer Field

The market cap of Medinova Diagnostic Services Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 41.90 Cr. as of now.

What is the 52 Week High and Low of Medinova Diagnostic Services Ltd?

Answer Field

The 52 Week High and Low of Medinova Diagnostic Services Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 51.05 and ₹ 32.10.

How to Buy Medinova Diagnostic Services Ltd share?

Answer Field

You can trade in Medinova Diagnostic Services Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Medinova Diagnostic Services Ltd?

Answer Field

The 1 year returns on the stock has been -0.19%.

What is the Current Share Price of Medinova Diagnostic Services Ltd?

Answer Field

Medinova Diagnostic Services Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 42.01 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Medinova Diagnostic Services Ltd Share?

Answer Field

The market cap of Medinova Diagnostic Services Ltd for NSE ₹ 0.0 & for BSE ₹ 41.90 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Medinova Diagnostic Services Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Medinova Diagnostic Services Ltd share is 45.55.

What is the PB ratio of Medinova Diagnostic Services Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Medinova Diagnostic Services Ltd share is -1.63.

How to Buy Medinova Diagnostic Services Ltd Share?

Answer Field

You can trade in Medinova Diagnostic Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medinova Diagnostic Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Medinova Diagnostic Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medinova Diagnostic Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|